BCL-2

Ten daily doses of venetoclax at ART start shrank the intact SIV reservoir in macaques

Emory researchers report in Nature Microbiology that ten days of an approved blood-cancer drug, given as antiretroviral therapy began, left the intact SIV reservoir smaller nine months later. No animal was taken off ART to test rebound.